RT @FrontImmunol: New Research: Cladribine Treatment for MS Preserves the Differentiative Capacity of Subsequently Generated Monocytes, Whe…
RRIDs were included in the Frontiers in Immunology paper "Cladribine Treatment for MS Preserves the Differen…" (https://t.co/pz8YONzrLS). We appreciate the author's support of reproducibility. #methodsmatter #accelerateopenscience
Cladribine Treatment for MS Preserves the Differentiative Capacity of Subsequently Generated Monocytes, Whereas Its Administration In Vitro Acutely Influences Monocyte Differentiation but Not Microglial Activation https://t.co/xLT7qYRM2e
New article: Cladribine Treatment for MS Preserves the Differentiative Capacity of Subsequently Generated Monocytes, Whereas Its Administration In Vitro Acutely Influences Monocyte Differentiation but Not Microglial… https://t.co/CsuOcY2pn4 #MS #multiples